Heart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo-controlled trial.
about
Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial.Cardiovascular safety and benefits of GLP-1 receptor agonists.Cardiovascular effects of glucagon-like peptide-1 receptor agonist therapies in patients with type 1 diabetes.Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance.
P2860
Heart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo-controlled trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Heart rate acceleration with G ...... ind, placebo-controlled trial.
@en
Heart rate acceleration with G ...... ind, placebo-controlled trial.
@nl
type
label
Heart rate acceleration with G ...... ind, placebo-controlled trial.
@en
Heart rate acceleration with G ...... ind, placebo-controlled trial.
@nl
prefLabel
Heart rate acceleration with G ...... ind, placebo-controlled trial.
@en
Heart rate acceleration with G ...... ind, placebo-controlled trial.
@nl
P2093
P50
P356
P1476
Heart rate acceleration with G ...... lind, placebo-controlled trial
@en
P2093
Daniël H van Raalte
Lennart Tonneijck
Mark H H Kramer
Michaela Diamant
P356
10.1530/EJE-16-0507
P577
2016-10-24T00:00:00Z